This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Perspective

Nov. 30, 2011

The problem with generic drug labels

Globalization has undermined quality assurance for generic drugs. By Jamie E. Moss of Thomas Jefferson School of Law


By Jaime E. Moss


When your doctor prescribes a brand-name drug without writing "dispensed as written," and your pharmacist substitutes a generic drug, there is no guarantee that the generic will be identical to the name-brand in ingredients and effectiveness. This issue affects millions of Americans - 75 percent of dispensed prescription drugs are generic drugs - and it is something that the U.S. Supreme Court failed to fully address in Pliva v. Mens...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up